Source link : https://www.newshealth.biz/health-news/antiretroviral-abacavir-linked-with-cardiovascular-events-in-reprieve-trial/
People with HIV who took the antiretroviral drug abacavir (Ziagen) had an increased risk of major adverse cardiovascular events (MACE), according to an exploratory analysis of the REPRIEVE trial. Past use of abacavir increased the risk of MACE by 50% (risk-adjusted HR 1.50, 95% CI 1.04-2.15) and current use increased MACE risk by 42% (risk-adjusted […]
Author : News Health
Publish date : 2024-07-28 19:24:01
Copyright for syndicated content belongs to the linked Source.